Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Most

Showing results (11-20 of 101) with videos related to

Pageof 11
Sort By:
ACS Synthetic Biology|July 11, 2024
ShuffleAnalyzer: A Comprehensive Tool to Visualize DNA ShufflingFranz Schweiggert, Gregor Habeck, Patrick Most, et al.
Circulation Research|January 4, 2014
Cardiac calcium handling on trial: targeting the failing cardiomyocyte signalosomeSven T Pleger, Philip Raake, Hugo A Katus, et al.
Trends in Biotechnology|September 29, 2004
Hope for a broken heart?Patrick Most, Carmen Eicher, Mirko Völkers, et al.
Journal of Molecular and Cellular Cardiology|August 25, 2010
S100A1 gene therapy for heart failure: a novel strategy on the verge of clinical trialsDavid Rohde, Henriette Brinks, Julia Ritterhoff, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 9, 2013
S100A1 gene therapy in small and large animalsPatrick Most, Philip Raake, Christophe Weber, et al.
European Heart Journal|May 1, 2020
From traditional pharmacological towards nucleic acid-based therapies for cardiovascular diseasesUlf Landmesser, Wolfgang Poller, Sotirios Tsimikas, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|April 27, 2007
S100A1: a novel inotropic regulator of cardiac performance. Transition from molecular physiology to pathophysiological relevancePatrick Most, Andrew Remppis, Sven T Pleger, et al.
Journal of Cell Science|February 4, 2012
Orai1 deficiency leads to heart failure and skeletal myopathy in zebrafishMirko Völkers, Nima Dolatabadi, Natalie Gude, et al.
Plos One|November 19, 2013
MicroRNA-138 regulates hypoxia-induced endothelial cell dysfunction by targeting S100A1Anagha Sen, Shumei Ren, Carolin Lerchenmüller, et al.
Journal of Cardiovascular Translational Research|July 21, 2010
S100A1: a multifaceted therapeutic target in cardiovascular diseaseDavid Rohde, Julia Ritterhoff, Mirko Voelkers, et al.
Pageof 11

Showing results (11-20 of 101) with videos related to

Sort By:
Pageof 11
ACS Synthetic Biology|July 11, 2024
ShuffleAnalyzer: A Comprehensive Tool to Visualize DNA ShufflingFranz Schweiggert, Gregor Habeck, Patrick Most, et al.
Circulation Research|January 4, 2014
Cardiac calcium handling on trial: targeting the failing cardiomyocyte signalosomeSven T Pleger, Philip Raake, Hugo A Katus, et al.
Trends in Biotechnology|September 29, 2004
Hope for a broken heart?Patrick Most, Carmen Eicher, Mirko Völkers, et al.
Journal of Molecular and Cellular Cardiology|August 25, 2010
S100A1 gene therapy for heart failure: a novel strategy on the verge of clinical trialsDavid Rohde, Henriette Brinks, Julia Ritterhoff, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 9, 2013
S100A1 gene therapy in small and large animalsPatrick Most, Philip Raake, Christophe Weber, et al.
European Heart Journal|May 1, 2020
From traditional pharmacological towards nucleic acid-based therapies for cardiovascular diseasesUlf Landmesser, Wolfgang Poller, Sotirios Tsimikas, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|April 27, 2007
S100A1: a novel inotropic regulator of cardiac performance. Transition from molecular physiology to pathophysiological relevancePatrick Most, Andrew Remppis, Sven T Pleger, et al.
Journal of Cell Science|February 4, 2012
Orai1 deficiency leads to heart failure and skeletal myopathy in zebrafishMirko Völkers, Nima Dolatabadi, Natalie Gude, et al.
Plos One|November 19, 2013
MicroRNA-138 regulates hypoxia-induced endothelial cell dysfunction by targeting S100A1Anagha Sen, Shumei Ren, Carolin Lerchenmüller, et al.
Journal of Cardiovascular Translational Research|July 21, 2010
S100A1: a multifaceted therapeutic target in cardiovascular diseaseDavid Rohde, Julia Ritterhoff, Mirko Voelkers, et al.
Pageof 11